A deal with Illumina, a global medical research organisation, over the week to expand sequencing-based research and molecular diagnostics capabilities, is the latest indication 54gene is placing a long-bet on precision medicine in Nigeria and Africa.
54gene is arguably one of the fastest-growing te
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
